Fabino Enterprises Ltd vs Zenith Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Fabino Enterprises Ltd is ₹ 20.31 as of 27 Apr 15:30 . The P/E Ratio of Fabino Enterprises Ltd changed from 600 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Zenith Drugs Ltd changed from 11.2 on March 2024 to 0 on March 2022 . This represents a CAGR of -100.00% over 3 years The Market Cap of Fabino Enterprises Ltd changed from ₹ 6.3 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Zenith Drugs Ltd changed from ₹ 107.52 crore on March 2024 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 3 years The Dividend Payout of Fabino Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenith Drugs Ltd changed from 8.99 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Fabino Enterprises Ltd

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain.
The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana.
Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'.
A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc.
The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

About Zenith Drugs Ltd

Zenith Drugs Ltd was originally incorporated on November 15, 2000 as a Private Limited Company in the name of 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior.
Subsequently, Company was converted into Public Limited and consequently, the name of Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore.
With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients.
The Company is mainly engaged in the business of manufacturing and Trading of Medicines.

FAQs for the comparison of Fabino Enterprises Ltd and Zenith Drugs Ltd

Which company has a larger market capitalization, Fabino Enterprises Ltd or Zenith Drugs Ltd?

Market cap of Fabino Enterprises Ltd is 4 Cr while Market cap of Zenith Drugs Ltd is 77 Cr

What are the key factors driving the stock performance of Fabino Enterprises Ltd and Zenith Drugs Ltd?

The stock performance of Fabino Enterprises Ltd and Zenith Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fabino Enterprises Ltd and Zenith Drugs Ltd?

As of May 4, 2026, the Fabino Enterprises Ltd stock price is INR ₹20.31. On the other hand, Zenith Drugs Ltd stock price is INR ₹45.35.

How do dividend payouts of Fabino Enterprises Ltd and Zenith Drugs Ltd compare?

To compare the dividend payouts of Fabino Enterprises Ltd and Zenith Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.